Logo image of WHLR

WHEELER REAL ESTATE INVESTME (WHLR) Stock Fundamental Analysis

NASDAQ:WHLR - Nasdaq - US9630258468 - REIT

2.36  -0.11 (-4.45%)

After market: 2.3 -0.06 (-2.54%)

Fundamental Rating

2

Overall WHLR gets a fundamental rating of 2 out of 10. We evaluated WHLR against 129 industry peers in the Diversified REITs industry. There are concerns on the financial health of WHLR while its profitability can be described as average. WHLR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

WHLR had negative earnings in the past year.
WHLR had a positive operating cash flow in the past year.
WHLR had negative earnings in each of the past 5 years.
In the past 5 years WHLR always reported a positive cash flow from operatings.
WHLR Yearly Net Income VS EBIT VS OCF VS FCFWHLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.21%, WHLR is doing worse than 88.10% of the companies in the same industry.
WHLR has a worse Return On Equity (-163.14%) than 96.03% of its industry peers.
WHLR has a Return On Invested Capital of 3.85%. This is in the better half of the industry: WHLR outperforms 74.60% of its industry peers.
WHLR had an Average Return On Invested Capital over the past 3 years of 3.22%. This is in line with the industry average of 3.11%.
The 3 year average ROIC (3.22%) for WHLR is below the current ROIC(3.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -6.21%
ROE -163.14%
ROIC 3.85%
ROA(3y)-3.45%
ROA(5y)-3.39%
ROE(3y)-25.9%
ROE(5y)-21.3%
ROIC(3y)3.22%
ROIC(5y)3.13%
WHLR Yearly ROA, ROE, ROICWHLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

With a decent Operating Margin value of 30.32%, WHLR is doing good in the industry, outperforming 67.46% of the companies in the same industry.
In the last couple of years the Operating Margin of WHLR has grown nicely.
WHLR has a Gross Margin of 66.12%. This is comparable to the rest of the industry: WHLR outperforms 44.44% of its industry peers.
WHLR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 30.32%
PM (TTM) N/A
GM 66.12%
OM growth 3Y-5.13%
OM growth 5Y9.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.53%
GM growth 5Y-1.67%
WHLR Yearly Profit, Operating, Gross MarginsWHLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

More info and screens

2

2. Health

2.1 Basic Checks

WHLR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, WHLR has more shares outstanding
WHLR has more shares outstanding than it did 5 years ago.
WHLR has a worse debt/assets ratio than last year.
WHLR Yearly Shares OutstandingWHLR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M
WHLR Yearly Total Debt VS Total AssetsWHLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

2.2 Solvency

WHLR has an Altman-Z score of -0.45. This is a bad value and indicates that WHLR is not financially healthy and even has some risk of bankruptcy.
WHLR's Altman-Z score of -0.45 is on the low side compared to the rest of the industry. WHLR is outperformed by 92.06% of its industry peers.
WHLR has a Debt/Equity ratio of 18.96. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 18.96, WHLR is not doing good in the industry: 96.03% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 18.96
Debt/FCF N/A
Altman-Z -0.45
ROIC/WACC0.9
WACC4.3%
WHLR Yearly LT Debt VS Equity VS FCFWHLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

WHLR has a Current Ratio of 1.60. This is a normal value and indicates that WHLR is financially healthy and should not expect problems in meeting its short term obligations.
WHLR has a better Current ratio (1.60) than 66.67% of its industry peers.
WHLR has a Quick Ratio of 1.60. This is a normal value and indicates that WHLR is financially healthy and should not expect problems in meeting its short term obligations.
WHLR has a Quick ratio of 1.60. This is in the better half of the industry: WHLR outperforms 69.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.6
WHLR Yearly Current Assets VS Current LiabilitesWHLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for WHLR have decreased strongly by -449.43% in the last year.
WHLR shows a small growth in Revenue. In the last year, the Revenue has grown by 0.13%.
Measured over the past years, WHLR shows a quite strong growth in Revenue. The Revenue has been growing by 9.41% on average per year.
EPS 1Y (TTM)-449.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-501.04%
Revenue 1Y (TTM)0.13%
Revenue growth 3Y18.82%
Revenue growth 5Y9.41%
Sales Q2Q%-1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WHLR Yearly Revenue VS EstimatesWHLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
WHLR Yearly EPS VS EstimatesWHLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100K -200K -300K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WHLR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WHLR Price Earnings VS Forward Price EarningsWHLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of WHLR indicates a rather cheap valuation: WHLR is cheaper than 96.03% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.89
WHLR Per share dataWHLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WHLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WHEELER REAL ESTATE INVESTME

NASDAQ:WHLR (1/21/2025, 8:00:02 PM)

After market: 2.3 -0.06 (-2.54%)

2.36

-0.11 (-4.45%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)03-03 2025-03-03
Inst Owners13.95%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner Change0%
Market Cap3.09M
Analysts43.33
Price TargetN/A
Short Float %13.62%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF 0.12
P/B 0.12
P/tB 0.24
EV/EBITDA 7.89
EPS(TTM)-266.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)20.22
OCFY856.84%
SpS78.78
BVpS19.58
TBVpS9.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.21%
ROE -163.14%
ROCE 4.87%
ROIC 3.85%
ROICexc 4.08%
ROICexgc 4.18%
OM 30.32%
PM (TTM) N/A
GM 66.12%
FCFM N/A
ROA(3y)-3.45%
ROA(5y)-3.39%
ROE(3y)-25.9%
ROE(5y)-21.3%
ROIC(3y)3.22%
ROIC(5y)3.13%
ROICexc(3y)3.36%
ROICexc(5y)3.23%
ROICexgc(3y)3.41%
ROICexgc(5y)3.27%
ROCE(3y)4.07%
ROCE(5y)3.96%
ROICexcg growth 3Y2.58%
ROICexcg growth 5Y14.46%
ROICexc growth 3Y1.7%
ROICexc growth 5Y14.04%
OM growth 3Y-5.13%
OM growth 5Y9.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.53%
GM growth 5Y-1.67%
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 18.96
Debt/FCF N/A
Debt/EBITDA 8.48
Cap/Depr 103.79%
Cap/Sales 26.22%
Interest Coverage 1.22
Cash Conversion 46.18%
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.6
Altman-Z -0.45
F-Score5
WACC4.3%
ROIC/WACC0.9
Cap/Depr(3y)288.53%
Cap/Depr(5y)178.31%
Cap/Sales(3y)74.03%
Cap/Sales(5y)46.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-449.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-501.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.13%
Revenue growth 3Y18.82%
Revenue growth 5Y9.41%
Sales Q2Q%-1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.24%
EBIT growth 3Y12.72%
EBIT growth 5Y19.52%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y99.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.1%
OCF growth 3Y9.88%
OCF growth 5Y-0.99%